Clincosm LogoSign in Get a demo

solid tumor, adult

Showing 26 - 50 of 199
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
May 3, 2023

Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

Not yet recruiting
  • Solid Tumor, Adult
  • +4 more
  • (no location specified)
Apr 24, 2023

Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

Recruiting
  • Pancreas Cancer
  • +3 more
  • CAR-T cells
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Mar 10, 2023

Solid Tumor, Adult Trial in Australia (IOS-1002, IOS-1002 + PD-1 mAb)

Recruiting
  • Solid Tumor, Adult
  • Clayton, Australia
  • +4 more
Mar 15, 2023

Solid Tumor, Adult Trial in Beijing (HS248 pieces)

Recruiting
  • Solid Tumor, Adult
  • HS248 pieces
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 6, 2023

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting
  • PIK3CA Mutation
  • +7 more
  • (no location specified)
Mar 7, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

Solid Tumor, Adult Trial in Geneva, Zürich (MVX-ONCO-2)

Withdrawn
  • Solid Tumor, Adult
  • MVX-ONCO-2
  • Geneva, Switzerland
  • +1 more
Jan 27, 2023

Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

Completed
  • Solid Tumor, Adult
  • Minneapolis, Minnesota
  • +2 more
Jan 27, 2023

Solid Tumor, Adult Trial in Tomsk (Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1)

Enrolling by invitation
  • Solid Tumor, Adult
  • Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1
  • Tomsk, Russian Federation
    TomskNRMC
Jan 23, 2023

Relapsed Solid Tumor, Refractory Cancer, Solid Tumor, Adult Trial (STI-3258)

Withdrawn
  • Relapsed Solid Neoplasm
  • +2 more
  • STI-3258
  • (no location specified)
Jan 24, 2023

Solid Tumor, Adult Trial (AK119, AK112)

Not yet recruiting
  • Solid Tumor, Adult
  • (no location specified)
Jan 10, 2023

Solid Tumor, Solid Carcinoma, Solid Tumor, Adult Trial in United States (Benralizumab)

Recruiting
  • Solid Tumor
  • +3 more
  • Basking Ridge, New Jersey
  • +4 more
Jan 18, 2023

Solid Tumor, Metastatic Solid Tumor, Solid Carcinoma Trial in New York, Seattle (AZD1390, Stereotactic Body Radiotherapy)

Not yet recruiting
  • Solid Tumor
  • +5 more
  • AZD1390
  • Stereotactic Body Radiotherapy
  • New York, New York
  • +1 more
Jan 12, 2023

Solid Tumor, Adult Trial in Orlando, Cincinnati (ADA-011, PD(L)-1 inhibitor)

Recruiting
  • Solid Tumor, Adult
  • Orlando, Florida
  • +1 more
Jan 6, 2023

Solid Tumor, Adult Trial in Belgium, France (DT-9081 - dose escalation, DT-9081 - expansion)

Recruiting
  • Solid Tumor, Adult
  • DT-9081 - dose escalation
  • DT-9081 - expansion
  • Anderlecht, Belgium
  • +3 more
Jan 5, 2023

Solid Tumor, Adult Trial in Shanghai (3D011-08)

Recruiting
  • Solid Tumor, Adult
  • Shanghai, Floor 2, Building 2, 270 Dong 'an Road, Xuhui District, China
    Fudan University Shanghai Cancer Center
Jan 2, 2023

Solid Tumor, Adult, Refractory Cancer Trial (GV20-0251)

Not yet recruiting
  • Solid Tumor, Adult
  • Refractory Cancer
  • (no location specified)
Dec 21, 2022

Solid Tumor, Adult Trial in Tianjin (AK119, AK104)

Recruiting
  • Solid Tumor, Adult
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insitute & Hospital
Dec 28, 2022

Adapting for Latinx PopulationsIntervention That Involves

Recruiting
  • Solid Tumor
  • +2 more
  • CONVO intervention
  • Bronx, New York
  • +3 more
Dec 21, 2022

Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer Trial (HST-1011, Cemiplimab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
Dec 14, 2022

Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA401 (Phase Ia), IMA401 (Phase Ib))

Recruiting
  • Refractory Cancer
  • +3 more
  • IMA401 (Phase Ia)
  • IMA401 (Phase Ib)
  • Tübingen, Baden-Wurttemberg, Germany
  • +16 more
Dec 19, 2022

Solid Tumor, Adult Trial in Australia, Hong Kong (CS1002, CS1003)

Completed
  • Solid Tumor, Adult
  • Albury, New South Wales, Australia
  • +9 more
Dec 15, 2022

Solid Tumor, Adult, Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in India (AUR105)

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Vadodara, Gujarat, India
  • +6 more
Dec 14, 2022